UPDATE | October 28, 2025

Analytical method co-qualification: A strategy to enhance operaitonal efficiency and accelerate development timelines

  • MAIL

Analytical method co qualification A strategy to enhance operaitonal efficiency and accelerate development timelines


Samsung Biologics is helping to define a new benchmark for analytical assurance in biomanufacturing. 


Data-driven and designed to reinforce method robustness as well as detect performance drifts in time, Samsung Biologics’ assay performance monitoring (APM) program proactively strengthens regulatory compliance while minimizing batch release delays.


Explore more insights in our latest Q&A whitepaper.

 

Analytical method co qualification A strategy to enhance operaitonal efficiency and accelerate development timelines


Samsung Biologics is helping to define a new benchmark for analytical assurance in biomanufacturing. 


Data-driven and designed to reinforce method robustness as well as detect performance drifts in time, Samsung Biologics’ assay performance monitoring (APM) program proactively strengthens regulatory compliance while minimizing batch release delays.


Explore more insights in our latest Q&A whitepaper.

Share article

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required